Calian Group (TSE:CGY – Get Free Report) received a C$106.00 target price from equities researchers at Ventum Financial in a report released on Thursday,BayStreet.CA reports. The firm presently has a “buy” rating on the stock. Ventum Financial’s price objective would indicate a potential upside of 41.11% from the company’s previous close.
Other equities research analysts have also recently issued research reports about the company. Desjardins upped their price target on Calian Group from C$104.00 to C$109.00 and gave the stock a “buy” rating in a report on Friday, August 14th. Canaccord Genuity Group boosted their target price on Calian Group from C$103.00 to C$105.00 and gave the stock a “buy” rating in a report on Monday, June 29th. Royal Bank Of Canada boosted their price target on Calian Group from C$90.00 to C$105.00 and gave the stock an “outperform” rating in a research report on Friday, August 14th. Stifel Nicolaus set a C$100.00 price target on shares of Calian Group and gave the company a “buy” rating in a report on Wednesday, May 20th. Finally, ATB Cormark Capital Markets increased their price objective on shares of Calian Group from C$92.50 to C$98.50 and gave the stock an “outperform” rating in a research note on Tuesday, May 19th. Nine investment analysts have rated the stock with a Buy rating, According to MarketBeat, the company currently has a consensus rating of “Buy” and an average price target of C$101.72.
Get Our Latest Stock Analysis on CGY
Calian Group Price Performance
Calian Group (TSE:CGY – Get Free Report) last posted its quarterly earnings data on Thursday, August 13th. The company reported C$1.10 earnings per share for the quarter. Calian Group had a net margin of 4.41% and a return on equity of 11.67%. The firm had revenue of C$230.40 million during the quarter. As a group, analysts predict that Calian Group will post 4.9475219 earnings per share for the current year.
Calian Group Company Profile
Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management. The Advanced Technologies segment includes Engineering Solutions and Services; Nuclear and Environmental Services; Satcom; DOCSIS; Electronics Design and Manufacturing and Agricultural Technology.
See Also
- Five stocks we like better than Calian Group
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Receive News & Ratings for Calian Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calian Group and related companies with MarketBeat.com's FREE daily email newsletter.
